These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 31573853)

  • 1. Imaging of Metastatic Germ Cell Tumors in Male Patients From Initial Diagnosis to Treatment-Related Toxicities: A Primer for Radiologists.
    Wood MJ; Thomas R; Howard SA; Braschi-Amirfarzan M
    AJR Am J Roentgenol; 2020 Jan; 214(1):24-33. PubMed ID: 31573853
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum tumor markers and testicular germ cell tumors: a primer for radiologists.
    Marshall C; Enzerra M; Rahnemai-Azar AA; Ramaiya NH
    Abdom Radiol (NY); 2019 Mar; 44(3):1083-1090. PubMed ID: 30539249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metastatic non-seminomatous germ cell tumor with vena cava and vertebral involvement.
    Gorin MA; Mullins JK; Allaf ME
    Int J Urol; 2013 Apr; 20(4):459-60. PubMed ID: 22989290
    [No Abstract]   [Full Text] [Related]  

  • 4. The Role of Imaging in the Diagnosis, Staging, Response to Treatment, and Surveillance of Patients with Germ Cell Tumors of the Testis.
    Thomas LJ; Brooks MA; Stephenson AJ
    Urol Clin North Am; 2019 Aug; 46(3):315-331. PubMed ID: 31277727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Positron emission tomography with [18 F]-2-fluoro-2-deoxy-D-glucose (18FDG-PET) in diagnosis of retroperitoneal lymph node metastases of testicular tumors].
    Müller-Mattheis V; Reinhardt M; Gerharz CD; Fürst G; Vosberg H; Müller-Gärtner HW; Ackermann R
    Urologe A; 1998 Nov; 37(6):609-20. PubMed ID: 9887489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Significance of Spermatic Cord Involvement by Testicular Germ Cell Tumors: Should We Be Staging Discontinuous Invasion From Involved Lymphovascular Spaces Differently From Direct Extension?
    Sanfrancesco JM; Trevino KE; Xu H; Ulbright TM; Idrees MT
    Am J Surg Pathol; 2018 Mar; 42(3):306-311. PubMed ID: 29309304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Management of metastatic testicular germ cell tumors].
    Lavaud P; Baciarello G; Fizazi K
    Bull Cancer; 2019 Oct; 106(10):896-902. PubMed ID: 31466695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A Case of Metastatic Seminomatous Testicular Tumor with Complicated Diagnosis by FDG-PET].
    Hashizume A; Mizuno N; Kawai M; Kishida T
    Hinyokika Kiyo; 2016 Jul; 62(7):383-7. PubMed ID: 27569358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metastatic Mature Teratoma and Growing Teratoma Syndrome in Patients with Testicular Non-Seminomatous Germ Cell Tumors.
    Green DB; La Rosa FG; Craig PG; Khani F; Lam ET
    Korean J Radiol; 2021 Oct; 22(10):1650-1657. PubMed ID: 34402242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PET in testicular cancer.
    Becherer A
    Methods Mol Biol; 2011; 727():225-41. PubMed ID: 21331937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Placental Site Trophoblastic Tumor in Nonseminomatous Mixed Germ Cell Tumors of the Testis: a Case Report and Review of the Literature.
    Razafimahefa J; Gosset C; Culine S; Mongiat-Artus P; Verine J
    Clin Genitourin Cancer; 2018 Apr; 16(2):e349-e354. PubMed ID: 29395947
    [No Abstract]   [Full Text] [Related]  

  • 12. Managing seminomatous and nonseminomatous germ cell tumors.
    Chahoud J; Zhang M; Shah A; Lin SH; Pisters LL; Tu SM
    Curr Opin Oncol; 2018 May; 30(3):181-188. PubMed ID: 29538040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Relapses of malignant nonseminomatous germinal testicular tumors].
    Piot G; Droz JP; Caillaud JM; Bellet D; Wibault P; Brulé G; Amiel JL
    J Urol (Paris); 1983; 89(1):49-51. PubMed ID: 6302168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PET imaging in the management of tumors of testis and ovary: current thinking and future directions.
    Basu S; Rubello D
    Minerva Endocrinol; 2008 Sep; 33(3):229-56. PubMed ID: 18846028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is postchemotherapy retroperitoneal surgery necessary in patients with nonseminomatous testicular cancer and minimal residual tumor masses?
    Fosså SD; Qvist H; Stenwig AE; Lien HH; Ous S; Giercksky KE
    J Clin Oncol; 1992 Apr; 10(4):569-73. PubMed ID: 1312586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poor prognosis of retroperitoneal mixed extragonadal germ cell tumors in an HIV-infected man with severe immunosuppression and bilateral cryptorchidism: a case report.
    Li R; Li H
    BMC Cancer; 2019 Mar; 19(1):244. PubMed ID: 30885154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Embryonic stem cell transcription factor signatures in the diagnosis of primary and metastatic germ cell tumors.
    Santagata S; Ligon KL; Hornick JL
    Am J Surg Pathol; 2007 Jun; 31(6):836-45. PubMed ID: 17527070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contemporary management of postchemotherapy testis cancer.
    Daneshmand S; Albers P; Fosså SD; Heidenreich A; Kollmannsberger C; Krege S; Nichols C; Oldenburg J; Wood L
    Eur Urol; 2012 Nov; 62(5):867-76. PubMed ID: 22938868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spontaneous regression of testicular germ cell tumors: an analysis of 42 cases.
    Balzer BL; Ulbright TM
    Am J Surg Pathol; 2006 Jul; 30(7):858-65. PubMed ID: 16819328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular Imaging for Evaluation of Viable Testicular Cancer Nodal Metastases.
    Joice GA; Rowe SP; Gorin MA; Pierorazio PM
    Curr Urol Rep; 2018 Nov; 19(12):110. PubMed ID: 30413968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.